Introduction
Cancer is a disease that involves complex bidirectional interactions between oncogenically transformed cells and their surrounding neighbors, both positive and negative. However, our current understanding of cancer is largely limited to the events in the transformed cell that disrupt the normal controls on cell proliferation, survival, and mortality (Hanahan and Weinberg, 2000) . Current viewpoints portray the Rb pathway as integrating the input of various mitogenic and antimitogenic signals, acting as a gatekeeper of cell proliferation (Hanahan and Weinberg, 2000; Ho and Dowdy, 2002) . Inactivation of the p53 pathway is nearly as common as inactivation of the Rb pathway. p53 is a major mediator of an oncogene-associated apoptotic pathway, and can also play an important role in maintaining genomic integrity and insuring mortality (Hanahan and Weinberg, 2000; Igney and Krammer, 2002) .
In oncogene-expressing cells, the p53 pathway is activated when the proliferating cell receives a signal that prevents its completion of the cell cycle. This was first exemplified in E1A-expressing fibroblasts (de Stanchina et al., 1998) . Proliferating E1A-expressing cells undergo apoptosis when treated with drugs that inhibit DNA replication. This drug-induced apoptotic event was dependent on two proteins, Arf and p53. Arf is a positive regulator of p53 (de Stanchina et al., 1998; Sherr, 1998 Sherr, , 2001 Zindy et al., 1998; Weber et al., 1999; Sherr and Weber, 2000) and its accumulation is controlled, at least in part, by E2F1 (Dimri et al., 2000; Jacobs et al., 2000; Parisi et al., 2002) , linking the proliferation pathway to a sentinel pathway that monitors it. A key consideration of the sentinel pathway is that physiologic levels of Arf alone are not sufficient to trigger apoptosis; apoptosis requires that the Arfpositive cell be treated in a way that inhibits continuation in the cell cycle.
Disruption of the Rb pathway alone is sufficient to result in a small focus of proliferating melanotroph tumor cells in the pars intermedia of the pituitary (Nikitin and Lee, 1996) . The number of cells in this lesion is kept in check by apoptosis. Apoptosis in the early lesions is associated with the proximity of the cells to the dopaminergic neurons (Nikitin and Lee, 1996) . Consistent with a role for dopamine signaling in the apoptotic event, injecting mice with a dopamine analog, bromocriptine, increases the frequency of apoptosis in the early lesions (Nikitin and Lee, 1996) . During a lengthy latency period, other mutations must accumulate, which can ultimately disrupt the balance of proliferating and dying cells allowing the lesion to progress into a tumor mass (Nikitin and Lee, 1996) .
Crossing the Rb+/À genotype into a background of p53-deficient (Williams et al., 1994) or Arf-deficient mice (Tyler Jacks, personal communication) accelerates development of pituitary tumors, but does not alleviate the requirement to lose the wild-type (wt) allele of Rb. Surprisingly, crossing the Rb+/À genotype onto a p27À/À background also accelerated the development of pituitary tumors without alleviating the requirement to lose the wt allele of Rb (Park et al., 1999) . p27 is involved in withdrawing cells from the cell cycle in response to extracellular signals (Casaccia-Bonnefil et al., 1997; Millard et al., 1997; Durand et al., 1998; Tong et al., 1998; Drissi et al., 1999; Lowenheim et al., 1999; Zezula et al., 2001) . In the pituitary, p27 cooperates with p18 to maintain the pituitary cells in a quiescent state (Franklin et al., 1998) . In this report, we wanted to determine how the absence of p27 accelerates tumor formation in Rb+/À mice. Our results suggest that p27 deficiency alleviates the selective pressure of the tumor cell to inactivate the Arf pathway. We discuss the implications of these results with respect to the role of p27 in tumor development.
Results
Bromocriptine induces cell cycle withdrawal in p27À/À, RbÀ/À, and RbÀ/Àp27À/À pituitary tumor cells Melanotrophs in the pars intermedia withdraw from the cell cycle within the first few weeks after birth. Dopamine, produced locally in the neurons of the pars distalis, induces cell-cycle exit in these cells (Chronwall et al., 1987) . p27À/À animals develop hyperplasia and adenoma in the pars intermedia and proliferating cells are detected throughout the life of the animal (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Although we could not directly measure local dopamine production, the neurons of the pars distalis did express tyrosine hydroxylase, the rate-limiting enzyme for dopamine synthesis (Figure 1 ) (reviewed in Swerdlow, 1998) .
To determine if the p27-deficient cells were capable of responding to dopamine, we treated mice with the dopamine analog bromocriptine (BrCPT), which interacts with the dopamine receptor and acts as a dopamine analog both in mouse and rat pars intermedia cells (Arita et al., 1998; Nikitin and Lee, 1996; Yin et al., 1999) . Animals were injected daily for 7 days and melanotrophs proliferation was examined by Ki67 staining (Figure 2 ) and BrdU incorporation (data not shown). We observed that BrCPT treatment reduced cell proliferation in the pars intermedia of p27À/À tumors ( Figure 2 ). Together with Figure 1 Tyrosine hydroxylase is expressed in the pars distalis of p27À/À mice. Pituitaries were isolated from wt and p27-deficient mice, sectioned and stained with either tyrosine hydroxylase-specific antibody (THase) or a mock rabbit-anti-mouse antibody (RaM). THase appears as a diffuse positive brown-staining signal. The pars distalis (D) and pars intermedia (I) are shown. Magnification is Â 100. The results are representative of two animals from each genotype at PND 30 and 60
Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al the observation that neurons of the pars distalis were tyrosine hydroxylase positive (Figure 1 ), we suggest that the absence of p27 altered the threshold above which dopamine was able to induce cell-cycle exit in melanotrophs. We next asked whether BrCPT would induce withdrawal of tumor cells in Rb+/À or Rb+/Àp27À/À mice. We had previously shown by PCR that these tumor cells had lost the remaining wt allele (Park et al., 1999) and we confirm this finding by immunoblot (representative example in Figure 4 ). Proliferation of these cells measured by either Ki67 staining (Figure 2 ) or BrdU incorporation (data not shown) was much greater than that observed in p27À/À mice, but similar between the two genotypes. BrCPT treatment induced cell-cycle exit in both mouse strains (Figure 2 ). We concluded that there was neither a proliferative advantage nor a change in response to BrCPT in cells lacking both Rb and p27 proteins compared to those that lack Rb alone.
Response of RbÀ/À and RbÀ/Àp27À/À cells to growth arrest induced by dopamine was different and correlated to the accumulation of Arf
We examined then the consequence of BrCPT-induced withdrawal. We observed that apoptosis was increased, as measured by the appearance of TUNEL-positive cells, in the Rb+/Àp27À/À deficient mice compared to that of the Rb+/À mice ( Figure 3 ). There were no TUNEL-positive fields detected in p27-deficient or wt mice treated in a similar manner. Thus, bromocriptineinduced cell-cycle exit was correlated with increased apoptosis in RbÀ/Àp27À/À cells but not RbÀ/À cells.
As dopamine-induced apoptosis is dependent on p53 (Yin et al., 1999) , we asked if the status of p53 was different in the tumors. We observed similar amounts of p53 in all tumors regardless of the genotype (Figure 4 ). SSCP analysis of three tumors from Rb+/À and Rb+/ Àp27À/À animals indicated that the p53 locus was wt at the DNA level (data not shown). This is consistent with Figure 2 Bromocriptine-induced cell-cycle exit in the tumors arising in p27À/À, Rb+/À, and Rb+/Àp27À/À mice. Animals were treated as described in the text, and sections of tissue were stained with Ki67 antibody. Ki67-positive cells have a brown nuclear stain. No staining was observed in controls where primary antibody was omitted (data not shown). Representative fields of the intermediate lobe tissue (wt and p27À/À) and melanotroph tumor tissue (Rb+/À and Rb+/Àp27À/À) are shown. Magnification is Â 1000. The graph compiles data on tumors (p27À/À, n ¼ 2; Rb+/À, n ¼ 2; Rb+/Àp27À/À, n ¼ 3) for Ki67 expression. The y-axis presents the percentage of positive cells in a Â 400 field. In all, 5-10 randomly chosen fields counted on at least two different sections of tumor were used to compile the mean and standard deviation Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al the observation that p53 was not frequently deregulated, mutated, or lost in tumors arising in Rb+/À mice (Williams et al., 1994) .
As p53 amount is controlled in part by Arf, we checked next if there was any difference in Arf expression between the tumors. The amount of Arf protein was higher in RbÀ/Àp27À/À tumors compared to the amount in RbÀ/À tumors ( Figure 4 ) and was undetectable in both wt tissue and adenoma from p27-deficient mice. From these data, we cannot determine if accumulation of Arf was reduced in the RbÀ/À tumor cells or increased in the RbÀ/Àp27À/À tumor cells. Using PCR with appropriate primers, we were able to detect Arf sequences from RbÀ/À tumors (7/7) (data not shown).
We also examined cdk2, cyclin E, cyclin A, and p21 to see if there was any correlation between their expression and genotype (Figure 4) . The only correlation that could be made was that cyclin E was more abundant in tumors from Rb+/Àp27À/À and Rb+/À animals than from p27À/À animals. Weinberg and his colleagues described this phenomenon previously in RbÀ/À mouse embryo fibroblasts (MEFs) in culture (Herrera et al., 1996) . The lack of cyclin E detection in p27À/À tumor extract is not biologically significant, but rather is associated with the relative expression level in the extracts prepared from RbÀ/À and p27À/À mouse tumors (unpublished data). p27À/À does not increase the expression of Arf in Rb null mouse fibroblasts
Because we could not determine if Arf levels were reduced in RbÀ/À tumors or increased in RbÀ/Àp27À/ À tumors, we sought to look at the interplay between Arf and p27 in another experimental system. We looked at early passage mouse embryo fibroblasts.
The doubling times of p27-deficient and wt cells were comparable and less than that of cells deficient for Rb or for both Rb and p27 (Figure 5a ). Cells deficient for Rb or both Rb and p27 had nearly equivalent doubling times. Furthermore, when cells were grown to confluence they withdrew to an equivalent degree (less than 10% of the cells incorporated BrdU during a 6 h pulse), indicating that they were responsive to the antimitogenic signals associated with confluence (Figure 5a , inset). However, it was noted that RbÀ/Àp27À/À cells arrest at a higher density than RbÀ/À cells (data not shown) and had a higher plating efficiency (Figure 5b ), both hallmarks of transformation.
p27À/À, RbÀ/À, or RbÀ/Àp27À/À cells were not immortal when passaged on a strict 3T3 protocol, reaching crises somewhere between passage 7 and 10 ( Figure 5c ). However, we found that Rb-p27 doubledeficient cells more readily escape this crisis and become immortalized at a greater frequency. Consequently, the rates of proliferation in Rb-deficient and Rb-p27-deficient cells and their ability to withdraw from the cell cycle were equivalent in primary mouse fibroblasts, similar to the features we observed in tumor melanotrophs.
We next asked whether Arf was increased in RbÀ/Àp27À/À cells in comparison with the RbÀ/À cells. We observed that Arf increased in both passage 1 RbÀ/À and RbÀ/Àp27À/À mouse embryo fibroblasts compared to wt or p27À/À cells (Figure 6 ). Arf, p53, p21, and cyclin A levels were comparable in RbÀ/À and RbÀ/Àp27À/À cells and higher than that in wt or p27À/ À cells (Figure 6 ). Consequently, Rb lost was sufficient to induce Arf accumulation and absence of p27 did not conspire with an Rb deficiency to elevate Arf expression levels. Figure 3 Bromocriptine-induced apoptosis in tumors arising in Rb+/Àp27À/À mice. Animals were treated as described in the text and tissues were sectioned and stained for apoptotic bodies by TUNEL staining as described in the Materials and methods. Representative fields from Rb+/Àp27À/À and Rb+/À animals are shown. Magnification is Â 1000. The graph compiles data on tumors (p27À/À, n ¼ 2; Rb+/À, n ¼ 3; Rb+/Àp27À/À, n ¼ 3). The y-axis presents the number of Â 1000 fields in which TUNELpositive cells were observed. In all, 7-15 randomly chosen fields per animal counted on at least two different sections of tumor were used to compile the data Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al
Combined loss of Rb and 27 does not eliminate Arf-dependent responses in fibroblasts
We also wanted to determine if p27 loss affected signaling though the Arf pathway. To determine if the combined loss of Rb and p27 attenuates the function of Arf, we examined the effect of introducing rasV12 into RbÀ/À and RbÀ/Àp27À/À early passage mouse fibroblasts. RasV12 induces senescence in early passage mouse embryo fibroblasts in an Arf and p53 dependent manner (Serrano et al., 1997) . Introducing rasV12 into RbÀ/À and RbÀ/Àp27À/À cells induced accumulation of Arf, p53, and p21 to similar levels ( Figure 6 ). Cell growth, as measured by staining the cells with crystal violet, slowed in rasV12-expressing cells regardless of their genotype (Figure 6 ). Proliferation, as measured by tritiated thymidine incorporation, on day 4 (Figure 6 ) or day 6 (data not shown) was similarly reduced in rasV12-expressing cells. Furthermore, a similar proportion of rasV12-expressing cells stain positively with SA-b-gal on day 4 ( Figure 6 ) and day 6 (data not shown). Together, these data indicate that rasV12 expression caused senescence in both RbÀ/À and RbÀ/Àp27À/À cells. This suggests that the combined Rb and p27 deficiencies do not attenuate Arf signaling in response to oncogene activation. Mouse models allow us to examine the contribution of p27 loss to the development of tumors induced at specific sites by specific mutations. In this report, we have attempted to understand how the absence of p27 accelerated pituitary tumor development in Rb+/À mice. We have shown that the combined loss of Rb and p27 did not increase either the rate of proliferation or the ability of a dopamine analog to inhibit melanotrophs proliferation, but it did alter the apoptotic response of the tumor cells to the analog. This correlates to an increase in the amount of Arf protein in RbÀ/Àp27À/À cells and suggests that the Arf-associated apoptotic pathway can be triggered in tumor cells arising in RbÀ/Àp27À/À mice. One interpretation of these data is that the absence of p27 alleviated the selection against Arf expression that normally occurs during tumor development in Rb+/À mice. Of course, this would be strengthened if we could show that tumors arising in Rb+/À animals selected against accumulation of Arf.
We could not directly use the tumor model to differentiate if the combination of Rb and p27 loss enhances Arf expression or whether Arf expression was lost during tumor development in Rb+/À mice. However, we report that MEFs have many characteristics similar to these tumor cells. This includes a comparable proliferation rate (RbÀ/Àp27À/ÀCRbÀ/ Àcwt ¼ p27À/À) and a comparable proliferative response to antimitogenic signals (melantrophs : BrCPT : fibroblasts:confluence). Furthermore, the Arf pathway is functional in RbÀ/Àp27À/À cells (BrCPT induces an Figure 4 Arf accumulates to higher levels in tumors arising in Rb+/Àp27À/À animals. Extracts were prepared from at least six independent tumors for each mutant mouse strain and from a pool of tissue isolated from wt mice as described in Materials and methods. The expression of Arf, p53, cyclin A, cyclin E, Rb, p27, p21, and cdk2 were determined as indicated by the respective blots. An asterisk marks nonspecific crossreactive bands in the Arf and Rb blots. Arf, p53, and cyclin E were run on a single gel containing multiple samples from each genotype to allow direct comparison of protein accumulation as a function of genotype. Cdk2, cyclin A, and p21 were expressed at variable levels within a given genotype and were thus run on gels containing a number of animals from a single genotype. A representative example of Rb and p27 blots is shown. This confirms that Rb protein is lost in the tumors arising in Rb+/À and Rb+/Àp27À/À mice Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al Figure 5 Arf expression is equivalent in RbÀ/À and RbÀ/Àp27À/À primary mouse embryo fibroblasts. Wt, p27À/À, and RbÀ/À primary mouse embryo fibroblasts were obtained from p27+/À or Rb+/À intercrosses, and RbÀ/Àp27À/À mouse embryo fibroblasts from crosses between Rb+/Àp27+/À females and Rb+/Àp27À/À males. (a) Growth kinetics of MEFs isolated from embryos with single and combined mutations in Rb and p27 (DKO). Passage 1 strains isolated from three independent embryos were analysed and a representative mean is indicated. (Inset) Confluence-induced arrest in MEFs isolated from embryos with single and combined mutations in Rb and p27. Tritiated thymidine incorporation of exponentially growing cultures (normalized to 100%) and cells grown to confluence for 14 days. The percent of proliferation at day 14, normalized for cell numbers is shown for each genotype. This experiment was performed with strains isolated from a wt embryo, four p27À/À embryos, two RbÀ/À embryos, and five RbÀ/Àp27À/ À embryos. The mean and s.d. of four independent experiments is shown. (b) Colony-forming efficiency in MEFs isolated from embryos with single and combined mutations in Rb and p27. The mean and s.d. of strains isolated from two wt embryos, three p27À/À embryos, two RbÀ/À embryos, and five RbÀ/Àp27À/À embryos are shown. (c) Crises are not significantly affected by single or combined mutations in Rb and p27. MEF strains were isolated from two wt embryos, three p27À/À embryos, two RbÀ/À embryos, and three RbÀ/Àp27À/À embryos Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al apoptotic response in melanotrophs, and rasV12 induces premature senescence in fibroblasts). Assuming that these similarities extend to the regulation of Arf, our MEF data inform us that the accumulation of Arf protein is not different in cells that lack either Rb alone or both Rb and p27. Thus in the Rb+/À pituitary tumor model, we suggest that p27 deficiency eliminates the period of selection for cells that reduced Arf. This provides genetic evidence that p27 status can impact on the Arf pathway.
In conclusion, there are two mechanisms by which the loss of p27 can accelerate tumor development. First, p27 is an antiproliferative tumor suppressor, as it had been shown in mouse models of prostate cancer associated with heterozygosity of Pten+/À (Di Cristofano et al., 2001) and colon cancer associated with heterozygosity of Min (Philipp-Staheli et al., 2002) . Placing either model into a p27-deficient background accelerates tumor development and there is a greater fraction of cycling cells in the tumors. Second, p27 is a pro- Figure 6 Expression of rasV12-induced senescence in both RbÀ/À and RbÀ/Àp27À/À cells. Cells at passage 1 were transduced with retroviruses expressing either rasV12 and a puromycin selectable marker or just the puromycin selectable marker, and after 4 days of selection, the cells were analysed. The genotypes of the cells are indicated above each column. The topmost graph shows the thymidine incorporation normalized for cell number measured by crystal violet assay performed in triplicate (control, squares; rasV12, diamonds). The second graph shows tritiated thymidine incorporation at day 4 performed in triplicate (control, white bars; rasV12 diamonds). The bottommost graph shows the percentage of cells staining positively for senescence-associated b-galactosidase performed in triplicate (control, white bars; rasV12, black bars). The expression of the ras protein, p53, p21, Arf, Rb, p27, and cyclin A are examined by immunoblot. An asterisk marks a nonspecific crossreactive band in the blots. The genotype, including p27À/À in this case, is shown above each lane. RasV12-transduced cells are indicated with a (+) sign. This experiment was repeated twice with strains isolated from independent embryos Genetic interaction of P27 and Arf during tumorigenesis C Carneiro et al apoptotic tumor suppressor. Rb+/À mice develop pituitary cancer that is associated with a reduction in Arf expression. Placing Rb+/À mice into a p27-deficient background accelerates tumor development (Park et al., 1999) without changing the fraction of cycling cells, but allows the tumor to progress without selecting for cells expressing lower amounts of Arf. In this model, p27 genetically acts to enable the Arf pathway and is thus a proapoptotic tumor suppressor. Both the antiproliferative and proapoptotic functions of p27 as a tumor suppressor are linked to its ability to inform the cell as to the antimitogenic environment.
Materials and methods

Genotyping and tissue isolation
PCR methods of genotyping the Rb and p27 loci were previously described (Park et al., 1999) . For immunohistochemistry, tissues were fixed in 10% buffered formalin overnight and then embedded in paraffin. For immunoblot, tumors were frozen immediately in liquid nitrogen, ground to a powder and sonicated in Tween 20 buffer .
Bromocriptine treatment
Mice were treated as described (Nikitin and Lee, 1996) . Bromocriptine (2-bromo-a-ergocryptine methanesulfonate, Sigma) was injected i.p. daily for 8 days at a dose of 3 mg/g of body weight. Animals were labeled with BrdU (100 mg/g of body weight) for 2 h and killed, 3 h after the last dose. Control animals were injected with 10% ethanol in 150 mm NaCl. Pituitaries were removed and stained for Ki67, TUNEL, or BrdU.
Immunohistochemical staining
For BrdU detection, sections were deparaffinized, treated 10 min at 371C with Proteinase K (5 mg/ml in 50 mm Tris, pH 7.5, 5 mm EDTA), washed with PBS and incubated in 1 N HCl for 10 min at 551C. Sections were then washed again with PBS and incubated with 0.1% H 2 O 2 in PBS for 15 min at room temperature to quench endogenous peroxidases. Blocking of nonspecific binding and incubation with primary, secondary, and tertiary reagents was performed following the MOM Immunohistochemistry Kit instructions (Vector Laboratories). For Ki67 staining, sections underwent antigen retrieval (microwaving to 1001C in 0.1 m citric acid for 5 min Â 3). The primary antibody used for Ki67 staining was mouse anti-Ki67 NCL Ki67MMI (Novocastra) at a final concentration of 1 : 200. The secondary antibody was biotinylated horse antimouse IgG. Tyrosine hydroxylase detection was performed by using anti-TH antibody (clone TH-2, Sigma) at 1 : 20 dilution and diaminobenzidine (DAB) as substrate. For TUNEL staining, sections were treated 15 min with Proteinase K (20 mg/ml in H 2 O). The labeling reaction was carried out by incubating the slides 1 h at 371C with 100 ml of the following mix: 30 mm Tris pH 7.2, 140 mm sodium cacodylate, 1 mm cobalt chloride, 30 U TdT, 5 mm biotin dUTP. In all cases, sections were subsequently counterstained with hematoxylin, dehydrated, and mounted.
Western blot of pituitary and MEF extracts
Immunoblots were carried out as described previously with the following changes: for detecting Arf and p53, 150 mg of tissue extract was loaded in a lane; for Rb detection, 90 mg of extract was used and for all other analysis, 30 mg extract was used. Membranes were incubated with the following antibodies: Arf (R562 AbCam), p53 (FL393, Santa Cruz), cyclin E (M20, Santa Cruz), cyclin A (C-19, Santa Cruz), cdk2 (M2, Santa Cruz), Rb (C15, Santa Cruz), p27 (C19 Santa Cruz), p21 (F5, Santa Cruz), and pan-ras (Ab3, Oncogene Research).
RasV12-induced senescence
The ecotropic virus packaging line Phoenix was obtained from G Nolan. Phoenix cells (2.5 Â 10 6 ) were plated in a 60 cm dish, incubated overnight and then transfected by superfect (Qiagen) with 7.5 mg of a retroviral plasmid according to manufacturers instruction. After 48 h, the virus-containing medium was filtered through a 0.45 mm filter (Nalge Nunc International) and supplemented with 4 mg/ml of polybrene (Sigma). Passage 1 MEFs were used for the experiments. For infections, virus-containing medium was applied to the MEF cells (8 Â 10 5 in 100 mm dish) and infection carried out at 371C overnight. After 16 h, infected cell populations were selected in 2 mg/ml of puromycin (Sigma) for 4 days.
Growth analysis was performed as previously described (Serrano et al., 1997) . Briefly, 20 000 cells per well were plated into 12-well plates. At the indicated times, cells were fixed with 10% formalin and stained with 0.1% crystal violet. Cellassociated dye was extracted with 10% acetic acid, diluted in H 2 O, and the optical density was determined by measuring at 590 nm. Within each experiment, each point was determined in triplicate.
For thymidine incorporation, 1000 cells per well were plated into 24-well plates at day 3. Cells were pulsed for 24 h with 2 mCi [methyl-3 H]thymidine (Amersham, 1 mCi/ml), washed with PBS, and detached using trypsin. Incorporated 3 H-labeled thymidine was precipitated in the presence of ice-cold 10% TCA for 5 min, collected on glass-fiber filters (Filtermat, Wallac), and quantified by scintillation counting. Within each experiment, each point was determined in triplicate.
Senescence-associated b-galactosidase activity was detected as previously described (Serrano et al., 1997) . Briefly, cells were plated into 24-well plates, washed with PBS (pH 7.2), fixed in 0.5% glutaraldehyde, and stained overnight at 371C in X-gal solution (1 mg/ml X-gal, 0.12 mm K 3 Fe[CN] 6 , 0.12 mm K 4 Fe[CN] 6 , 1 mm MgCl 2 in PBS at pH 6.0).
Growth properties of single and double mutant mouse embryo fibroblasts
Cells from wt, p27À/À, RbÀ/À, and RbÀ/Àp27À/À MEF strains at passage 1 were seeded at 1 Â 10 5 into individual wells of a 24-well tissue culture plate. Duplicate wells were harvested on the days indicated at the bottom of the graph, and the total number of cells per culture determined.
Colony-forming efficiency was assessed by plating 6 Â 10 3 passage 2 cells into a 10 cm dish and incubated for 2 weeks with regular changes of medium every 3 days. After 2 weeks, the dishes were stained with Giemsa and the number of colonies >2.5 mm in diameter scored.
To determine the period of crises, 3 Â 10 6 cells were seeded in a 10 cm dish at passage 3 and every 3 days, cells were counted and reseeded at the same density. The increase in population doubling level was calculated according to the formula: PDL ¼ log(n f /n 0 )log 2 where n 0 is the initial number of cells and n f the final number of cells.
